Introduction: Dyslipidaemia is one of the major risk factor for cardiovascular disease in Type 2 Diabetes mellitus, characterized by elevated Total cholesterol (TC), Triglycerides (TG), Low density lipoprotein (LDL) and decreased High density lipoprotein (HDL). Haemoglobin A1c (HbA1c) is widely used as an index of mean glycaemia, a measure of risk for the development of diabetes complications and a measure of the quality of diabetes care. The aim of this study was to determine the impact of glycaemic control on lipid profile and to know utility of HbA1c as an indirect indicator of dyslipidaemia. Objectives: To assess the relationship between glycemic control (HbA1c) and serum lipid profile as well as to evaluate the importance of HbA1...
Objectives: Dyslipidemia is one of the major risk factor for cardiovascular disease in Type 2 Diabet...
Background: Diabetes mellitus is the most common metabolic disease. Impaired lipid metabolism result...
Background: Patients with type 2 diabetes (T2DM) have an increased prevalence of dyslipidemia, which...
Introduction: Dyslipidaemia is one of the major risk factor for cardiovascular disease in Type 2 Dia...
Introduction: Diabetic patients with concomitant dyslipidemia are often soft targets for cardiovascu...
Background: Diabetes is a group of metabolic diseases characterized by hyperglycemia resulting from ...
Introduction: Hyperlipidemia is a common risk factor for diabetes and its cardiovascular complicatio...
Objective: To establish the correlation between glycated hemoglobin (HbA1c) and lipid profile in pat...
Type 2 diabetes mellitus (T2DM) is a chronic disease that develops due to defective insulin secretio...
Glycated haemoglobin (HbA1c) is an important indicator of long-term glycaemic control with the abili...
Background: Type 2 diabetes mellitus (T2DM) is a rapidly growing public health problem with signific...
Background: Type 2 diabetes mellitus (T2DM) is a rapidly growing public health problem with signific...
Introduction: Diabetes is one of the major burdens of non-communicable disease causing morbidity and...
The risk of coronary heart disease (CHD) is dramatically increased in diabetic patients due to their...
Introduction: One in every five Indians in geriatric age has diabetes. Diabetes is associated with i...
Objectives: Dyslipidemia is one of the major risk factor for cardiovascular disease in Type 2 Diabet...
Background: Diabetes mellitus is the most common metabolic disease. Impaired lipid metabolism result...
Background: Patients with type 2 diabetes (T2DM) have an increased prevalence of dyslipidemia, which...
Introduction: Dyslipidaemia is one of the major risk factor for cardiovascular disease in Type 2 Dia...
Introduction: Diabetic patients with concomitant dyslipidemia are often soft targets for cardiovascu...
Background: Diabetes is a group of metabolic diseases characterized by hyperglycemia resulting from ...
Introduction: Hyperlipidemia is a common risk factor for diabetes and its cardiovascular complicatio...
Objective: To establish the correlation between glycated hemoglobin (HbA1c) and lipid profile in pat...
Type 2 diabetes mellitus (T2DM) is a chronic disease that develops due to defective insulin secretio...
Glycated haemoglobin (HbA1c) is an important indicator of long-term glycaemic control with the abili...
Background: Type 2 diabetes mellitus (T2DM) is a rapidly growing public health problem with signific...
Background: Type 2 diabetes mellitus (T2DM) is a rapidly growing public health problem with signific...
Introduction: Diabetes is one of the major burdens of non-communicable disease causing morbidity and...
The risk of coronary heart disease (CHD) is dramatically increased in diabetic patients due to their...
Introduction: One in every five Indians in geriatric age has diabetes. Diabetes is associated with i...
Objectives: Dyslipidemia is one of the major risk factor for cardiovascular disease in Type 2 Diabet...
Background: Diabetes mellitus is the most common metabolic disease. Impaired lipid metabolism result...
Background: Patients with type 2 diabetes (T2DM) have an increased prevalence of dyslipidemia, which...